These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6804446)

  • 1. Clinical correlates of the TRH infusion test in primary depression.
    Kirstein L; Gold MS; Extein I; Martin D; Pottash AL
    J Clin Psychiatry; 1982 May; 43(5):191-4. PubMed ID: 6804446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and subtyping of depressive disorders by quantitative electroencephalography: III. Discriminating unipolar from bipolar depression.
    Lieber AL; Newbury ND
    Hillside J Clin Psychiatry; 1988; 10(2):165-72. PubMed ID: 3147236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone test and male unipolar depression.
    Kirstein L; Gold MS; Pottash AL; Extein I
    Biol Psychiatry; 1981 Sep; 16(9):819-24. PubMed ID: 6794655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between vasopressin baseline and TSH-blunting in depressives.
    Lenzinger E; Meszaros K; Hornik K; Parzer P; Hollerer E; Langer G; Resch F; Legros JJ
    Biol Psychiatry; 1996 Mar; 39(5):341-5. PubMed ID: 8704065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyrotrophin-releasing hormone (TRH) stimulation test in psychiatric patients].
    Duan Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Apr; 23(2):75-8, 125-6. PubMed ID: 2118064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologic diagnosis of depression by the TRH and dexamethasone tests].
    Chabrol H; Moron P
    Encephale; 1983; 9(1):1-22. PubMed ID: 6135596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R; Brown P; Bienenstock A; Mitton J
    Biol Psychiatry; 1984 Mar; 19(3):347-52. PubMed ID: 6426532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool].
    Babinski T; Paunović VR
    Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral ventricular size in major depressive disorder: association with delusional symptoms.
    Targum SD; Rosen LN; DeLisi LE; Weinberger DR; Citrin CM
    Biol Psychiatry; 1983 Mar; 18(3):329-36. PubMed ID: 6404312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thyrotropin releasing hormone stimulation test: a review.
    Sternbach H; Gerner RH; Gwirtsman HE
    J Clin Psychiatry; 1982 Jan; 43(1):4-6. PubMed ID: 6798028
    [No Abstract]   [Full Text] [Related]  

  • 18. The TRH stimulation test and reverse T3 in depression.
    Sternbach HA; Gwirtsman HE; Gerner RH; Hershman J; Pekary E
    J Affect Disord; 1985; 8(3):267-70. PubMed ID: 3160737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship among selected neuroendocrine and sleep measures in patients with recurrent depression.
    Kupfer DJ; Jarrett DB; Frank E
    Biol Psychiatry; 1984 Nov; 19(11):1525-36. PubMed ID: 6518206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.